5051
|
|
5052
|
|
5053
|
|
5054
|
|
5055
|
Buchanan JG. Cytosine arabinoside therapy for acute myeloid leukaemia in adults. N Z Med J 1971; 74:153-9. [PMID: 5289827] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/14/2023]
|
5056
|
Crowther D. Treatment of acute myelogenous leukaemia in adults. Br J Haematol 1971; 21:360-1. [PMID: 5285165] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/14/2023]
|
5057
|
Abstract
Meningeal involvement with Burkitt lymphoma cells constitutes the most challenging therapeutic problem in the management of Burkitt's tumour. The results of intrathecal chemotherapy with methotrexate or cytosine arabinoside in 55 episodes of malignant pleocytosis in 38 patients with Burkitt's tumour are described. The response was complete in nearly all patients after the administration of either agent. Cerebrospinal fluid (C.S.F.) remissions were more prolonged in patients receiving intrathecal methotrexate or cytosine arabinoside daily for four days as opposed to a 10-day schedule. A controlled randomized trial of "prophylactic" intrathecal chemotherapy in patients without malignant cells in the C.S.F. on admission showed no protective effect against the subsequent development of malignant pleocytosis. Future therapeutic approaches are considered in the light of these results.
Collapse
|
5058
|
|
5059
|
|
5060
|
|
5061
|
Baguley BC, Falkenhaug EM. Plasma half-life of cytosine arabinoside (NSC-63878) in patients treated for acute myeloblastic leukemia. Cancer Chemother Rep 1971; 55:291-8. [PMID: 5286668] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/14/2023]
|
5062
|
|
5063
|
Judd KP, Trentin JJ. Cardiac transplantation in mice. II. Effect of continuous immunosuppressive therapy on the survival of H-2-incompatible allografts. Transplantation 1971; 11:303-8. [PMID: 4934265 DOI: 10.1097/00007890-197103000-00010] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/13/2023]
|
5064
|
Yoshikawa K, Kitaoka H, Matsui K. [Continuous intra-arterial infusion of antineoplastic agents in cancerous peritonitis, with special reference to cancer]. Nihon Rinsho 1971; 29:1022-30. [PMID: 5102764] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/13/2023]
|
5065
|
Mathé G, Amiel JL, Schwarzenberg L, Schneider M, Hayat M, de Vassal F, Jasmin C, Rosenfeld C, Pouillart P. Preliminary result of a new protocol for the active immunotherapy of acute lymphoblastic leukaemia: inhibition of the immunotherapeutic effect by Vincristine or Adamantadine. Rev Eur Etud Clin Biol 1971; 16:216-24. [PMID: 4997294] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/13/2023]
|
5066
|
Cain BF. Experimental cancer chemotherapy: strategy for cure. N Z Med J 1971; 73:85-90. [PMID: 4994879] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/13/2023]
|
5067
|
Ritter EJ, Scott WJ, Wilson JG. Teratogenesis and inhibition of DNA synthesis induced in rat embryos by cytosine arabinoside. Teratology 1971; 4:7-13. [PMID: 5541179 DOI: 10.1002/tera.1420040103] [Citation(s) in RCA: 52] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/15/2023]
|
5068
|
|
5069
|
|
5070
|
|
5071
|
Bergsagel DE. An assessment of massive-dose chemotherapy of malignant disease. Can Med Assoc J 1971; 104:31-6. [PMID: 4322068 PMCID: PMC1930832] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/10/2023]
|
5072
|
Cytarabine. Med Lett Drugs Ther 1971; 13:3-4. [PMID: 5284023] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/14/2023]
|
5073
|
|
5074
|
Shackney SE. A computer model for tumor growth and chemotherapy, and its application to L1210 leukemia treated with cytosine arabinoside (NSC-63878). Cancer Chemother Rep 1970; 54:399-429. [PMID: 5527022] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/15/2023]
|
5075
|
Skipper HE, Schabel FM, Mellett LB, Montgomery JA, Wilkoff LJ, Lloyd HH, Brockman RW. Implications of biochemical, cytokinetic, pharmacologic, and toxicologic relationships in the design of optimal therapeutic schedules. Cancer Chemother Rep 1970; 54:431-50. [PMID: 5527023] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/15/2023]
|
5076
|
Crowther D, Bateman CJ, Vartan CP, Whitehouse JM, Malpas JS, Fairley GH, Scott RB. Combination chemotherapy using L-asparaginase, daunorubicin, and cytosine arabinoside in adults with acute myelogenous leukaemia. Br Med J 1970; 4:513-7. [PMID: 4921703 PMCID: PMC1820017 DOI: 10.1136/bmj.4.5734.513] [Citation(s) in RCA: 103] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/13/2023]
Abstract
Cytosine arabinoside and daunorubicin used in an intensive intermittent regimen have been shown to be an effective combination for the induction of complete remissions in 14 out of 23 adult patients with acute myelogenous leukaemia. This gives an overall complete remission rate of 60%. A further patient had a good partial remission. The addition of L-asparaginase to the regimen has not increased the incidence of remission and there were more side effects in the L-asparaginasetreated group. Of the 10 patients treated with L-asparaginase in addition to cytosine arabinoside and daunorubicin, five achieved a complete remission. Of the 13 patients treated with cytosine arabinoside and daunorubicin without L-asparaginase, nine achieved a complete remission and one a good partial remission.
Collapse
|
5077
|
Graham FL, Whitmore GF. The effect of-beta-D-arabinofuranosylcytosine on growth, viability, and DNA synthesis of mouse L-cells. Cancer Res 1970; 30:2627-35. [PMID: 5530557] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/15/2023]
|
5078
|
Amano I, Higo O, Oshima T, Horiuchi A, Morita K. [Treatment of acute myeloid leukemia by the combination therapy of 6-mercaptopurine and cytosine arabinoside--evaluation of twenty-two cases]. Saishin Igaku 1970; 25:1928-37. [PMID: 5272335] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/14/2023]
|
5079
|
Neil GL, Moxley TE, Manak RC. Enhancement by tetrahydrouridine of 1-beta-D-arabinofuranosylcytosine (cytarabine) oral activity in L1210 leukemic mice. Cancer Res 1970; 30:2166-72. [PMID: 4990003] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/13/2023]
|
5080
|
Cain BF. Experimental leukaemia chemotherapy: a perspective. N Z Med J 1970; 72:40-4. [PMID: 5273031] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/14/2023]
|
5081
|
Tatsumi N, Masaoka T, Ueda Y, Senda N. [Treatment of leukemia with cytosine arabinoside--on the intensification of remission]. Gan No Rinsho 1970; 16:706-12. [PMID: 5465488] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/15/2023]
|
5082
|
Burke PJ, Owens AH, Colsky J, Shnider BI, Edmonson JH, Schilling A, Brodovsky HS, Wallace HJ, Hall TC. A clinical evaluation of a prolonged schedule of cytosine arabinoside (NSC63878). Cancer Res 1970; 30:1512-5. [PMID: 5426952] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/15/2023]
|
5083
|
Neil GL, Wiley PF, Manak RC, Moxley TE. Antitumor effect of 1-beta-D-arabinofuranosylcytosine 5'-adamantoate (NSC 117614) in L1210 leukemic mice. Cancer Res 1970; 30:1047-54. [PMID: 5504347] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/15/2023]
|
5084
|
|
5085
|
|
5086
|
Halikowski B, Cyklis R, Armata J, Garwicz S, Wyszkowski J, Garapich M. Cytosine arabinoside administered intrathecally in cerebromeningeal leukemia. Acta Paediatr Scand 1970; 59:164-8. [PMID: 5266501 DOI: 10.1111/j.1651-2227.1970.tb08983.x] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/14/2023]
|
5087
|
|
5088
|
Finklestein JZ, Scher J, Karon M. Pharmacologic studies of tritiated cytosine arabinoside (NSC-63878) in children. Cancer Chemother Rep 1970; 54:35-9. [PMID: 5538163] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/15/2023]
|
5089
|
|
5090
|
|
5091
|
Abstract
Nine patients with acute lymphoblastic leukaemia in relapse were treated with a course of cytosine arabinoside followed immediately by a course of L-asparaginase. Eight patients achieved complete remission of their disease. This combination of drugs is sufficiently effective to suggest that further trial is needed. It is possible that the combination has a synergistic effect.
Collapse
|
5092
|
Rall DP. New approaches in administration of anticancer drugs. Cancer Res 1969; 29:2471-4. [PMID: 5369694] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/14/2023]
|
5093
|
Goldin A. Factors pertaining to complete drug-induced remission of tumor in animals and man. Cancer Res 1969; 29:2285-91. [PMID: 4917976] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/13/2023]
|
5094
|
Halikowski B, Cyklis R, Armata J, Garwicz S, Wyszkowski J, Garapich M. [Spinal administration of cytosine arabinose in a case of refractory meningocerebral leukemia]. Pediatr Pol 1969; 44:1283-7. [PMID: 5360559] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/14/2023]
|
5095
|
Hoffman GS, Kline I, Gang M, Tyrer DD, Goldin A, Mantel N, Venditti JM. Sequential chemotherapy with cyclophosphamide (NSC-26271) and cytosine arabinoside (NSC-63878) in mice with advanced leukemia L1210. Cancer Chemother Rep 1969; 53:265-71. [PMID: 5377613] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/14/2023]
|
5096
|
Lenaz L, Sternberg SS, Philips FS. Cytotoxic effects of 1-beta-D-arabinofuranosyl-5-fluorocytosine and of 1-beta-D-arabinofuranosylcytosine in proliferating tissues in mice. Cancer Res 1969; 29:1790-8. [PMID: 5823947] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/16/2023]
|
5097
|
|
5098
|
Frei E, Bickers JN, Hewlett JS, Lane M, Leary WV, Talley RW. Dose schedule and antitumor studies of arabinosyl cytosine (NSC 63878). Cancer Res 1969; 29:1325-32. [PMID: 5799155] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/16/2023]
|
5099
|
Ota K. Multiple combination therapy in cancer chemotherapy in Japan. Gan 1969; 60:239-46. [PMID: 4981311] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/13/2023]
|
5100
|
Bruce WR, Meeker BE, Powers WE, Valeriote FA. Comparison of the dose- and timesurvival curves for normal hematopoietic and lymphoma colony-forming cells exposed to vinblastine, vincristine, arabinosylcytosine, and amethopterin. J Natl Cancer Inst 1969; 42:1015-25. [PMID: 5793185] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/16/2023] Open
|